Expression profiles of EGFR, c-Met, and mTOR/Wnt alternative signaling pathway proteins in non-small cell lung cancer

被引：0
|
作者：
Shearrow, Caleb [1 ]
Crees, Zachary [1 ]
Girard, Jennifer [1 ]
Harrington, Kymberly [1 ]
Arasi, Kavin [1 ]
Bertram, Ceyda [2 ]
Nowak, Andrew [1 ]
Lin, Leo [1 ]
Sheu, Bonnie [1 ]
Palani, Sunil [1 ]
Puri, Neelu [1 ]
机构：
[1] Univ Illinois, Coll Med Rockford, Rockford, IL USA
[2] Rensselaer Polytech Inst, Albany, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-743
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
743
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer
    Crees, Zachary D.
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Berei, Joseph
    Eckburg, Adam
    Anderson, Austin D.
    Garcia, Christian
    Munger, Ariana
    Palani, Sunil
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Vitali, Connie
    David, Odile
    Puri, Neelu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [2] Mechanism of EGFR and c-Met TKI resistance and role of co-expression of EGFR and c-Met in non-small cell lung cancer patients
    Botting, Gregory Michael
    Harrington, Kymberly
    Shearrow, Caleb
    Crees, Zachary
    Girard, Jennifer
    Arasi, Kavin
    Puri, Neelu
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer
    Fu, Le
    Guo, Wei
    Liu, Bingshan
    Sun, Linlin
    Bi, Zhenghong
    Zhu, Li
    Wang, Xinyan
    Liu, Bin
    Xie, Qian
    Li, Ke
    BIOMARKERS, 2013, 18 (02) : 126 - 135
  • [4] Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer
    Fong, Jason T.
    Jacobs, Ryan J.
    Moravec, David N.
    Uppada, Srijayaprakash B.
    Botting, Gregory M.
    Nlend, Marie
    Puri, Neelu
    PLOS ONE, 2013, 8 (11):
  • [5] The role of HGF/C-met signalling pathway on the non-small cell lung cancer
    Gumustekin, M.
    Sis, B.
    Bulut, G.
    Kargi, A.
    Oztop, I.
    Olgun, N.
    Atabey, N.
    FEBS JOURNAL, 2006, 273 : 89 - 89
  • [6] Wnt Signaling Pathway in Non-Small Cell Lung Cancer
    Stewart, David J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (01):
  • [7] INTEGRIN BETA1 MEDIATES EGFR TKI RESISTANCE THROUGH C-MET SIGNALING PATHWAY IN NON-SMALL CELL LUNG CANCER
    Ju, L.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [8] Expression of c-Met and HGF in non-small cell lung carcinomas
    I. V. Korobko
    M. V. Zinov’eva
    E. P. Kopantsev
    A. K. Allakhverdiev
    I. B. Zborovskaya
    E. D. Sverdlov
    Molecular Genetics, Microbiology and Virology, 2007, 22 (2) : 59 - 63
  • [9] C-MET inhibitors for advanced non-small cell lung cancer
    Pasquini, Giulia
    Giaccone, Giuseppe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 363 - 375
  • [10] Correlation of expression of EGFR, cMET and mTOR signaling pathway proteins with each other and their impact on prognosis in non-small cell lung cancer patients
    Crees, Zachary
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Nowak, Andrew
    Sheu, Bonnie
    Chhabra, Gagan
    Sreenivassappa, Shylendra
    Vitali, Connie
    David, Odile
    Puri, Neelu
    CANCER RESEARCH, 2016, 76
12345